Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Jul-24 9:54 AM View:  | AP Pharma Inc. (HRTX) | 19-Jul-24 | Option Exercise | 13,797 | -- | -- | 5% 262.79K to 276.59K | |
| 20-Jun-24 5:30 PM View: | Terrascend Corp. (TSNDF) | 17-Jun-24 | Grant | 163,334 | -- | -- | 30% 553.51K to 716.85K | |
| 19-Apr-24 4:34 PM View: | AP Pharma Inc. (HRTX) | 19-Apr-24 | Option Exercise | 13,797 | -- | -- | 6% 249.0K to 262.79K | |
| 05-Apr-24 3:57 PM View: | AP Pharma Inc. (HRTX) | 03-Apr-24 | Option Exercise | 62,500 | -- | -- | 34% 186.5K to 249.0K | |
| 17-Nov-23 12:37 PM View: | AP Pharma Inc. (HRTX) | 16-Nov-23 | Private Purchase | 150,000 | $0.92 | $137,970.00 | 411% 36.5K to 186.5K | |
| 24-Aug-23 4:09 PM View: | AP Pharma Inc. (HRTX) | 22-Aug-23 | Payment of Exercise | 692 | $1.65 | $1,141.80 | (2%) 37.19K to 36.5K | |
| 26-Jun-23 2:40 PM View: | Terrascend Corp. (TSNDF) | 22-Jun-23 | Grant | 132,647 | -- | -- | 32% 420.87K to 553.51K | |
| 24-May-23 5:04 PM View: | AP Pharma Inc. (HRTX) | 22-May-23 | Payment of Exercise | 691 | $1.45 | $1,001.95 | (2%) 37.88K to 37.19K | |
| 03-Mar-23 9:25 AM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 02-Mar-23 | Disposition | 55,822 | $20.00 | $1,116,440.00 | (100%) 55.82K to 0 | |
| 27-Sep-22 12:00 PM View: | Terrascend Corp. (TSNDF) | 23-Sep-22 | Purchase | 60,000 | -- | -- | 17% 360.87K to 420.87K | |
| 26-Sep-22 12:26 PM View: | Terrascend Corp. (TSNDF) | 22-Sep-22 | Purchase | 120,000 | -- | -- | 50% 240.87K to 360.87K | |
| 01-Jul-22 4:37 PM View: | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 13,500 | $55.00 | $742,500.00 | (100%) 13.5K to 0 | |
| 29-Jun-22 9:08 PM View: | Terrascend Corp. (TSNDF) | 27-Jun-22 | Grant | 114,414 | -- | -- | 90% 126.45K to 240.87K | |
| 14-Jun-22 5:00 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 14-Jun-22 | Grant | 2,000 | -- | -- | 4% 53.82K to 55.82K | |
| 13-Jun-22 4:55 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 13-Jun-22 | Purchase | 4,037 | $10.94 | $44,148.60 | 8% 49.78K to 53.82K | |
| 13-Jun-22 4:55 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 10-Jun-22 | Private Purchase | 1,663 | $11.50 | $19,117.80 | 3% 48.12K to 49.78K | |
| 17-May-22 4:02 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 16-May-22 | Private Purchase | 27,150 | $13.54 | $367,611.00 | 129% 20.97K to 48.12K | |
| 16-May-22 4:05 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 13-May-22 | Private Purchase | 3,689 | $10.49 | $38,697.60 | 21% 17.28K to 20.97K | |
| 10-Jan-22 9:30 PM View: | Terrascend Corp. (TSNDF) | 06-Jan-22 | Exercise (in-the money or at-the-money) | 52,939 | $2.54 | $134,465.00 | 72% 73.51K to 126.45K | |
| 24-Nov-21 7:07 PM View: | Sierra Oncology, Inc. (SRRA) | 24-Nov-21 | Market Purchase | 7,899 | $23.08 | $182,348.00 | 141% 5.6K to 13.5K | (< 1%) |
| 24-Nov-21 7:07 PM View: | Sierra Oncology, Inc. (SRRA) | 23-Nov-21 | Market Purchase | 5,601 | $22.94 | $128,515.00 | 100% 0 to 5.6K | < 1% |
| 15-Sep-21 4:01 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 13-Sep-21 | Grant | 1,206 | $18.02 | $21,736.80 | 9% 13.58K to 14.78K | 8% |
| 15-Sep-21 4:01 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 13-Sep-21 | Market Purchase | 2,500 | $18.13 | $45,325.00 | 17% 14.78K to 17.28K | 7% |
| 13-Sep-21 4:08 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 10-Sep-21 | Market Purchase | 9,577 | $18.18 | $174,110.00 | 239% 4.0K to 13.58K | (< 1%) |
| 16-Jun-21 4:01 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 15-Jun-21 | Grant | 2,000 | -- | -- | 100% 2.0K to 4.0K | |
| 15-Jun-20 4:05 PM View: | Opiant Pharmaceuticals, Inc. (OPNT) | 15-Jun-20 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 04-Feb-14 10:58 AM View: | Critical Therapeutics Inc. (CRTX) | 03-Feb-14 | Disposition | 1,567,220 | $9.50 | $14,888,600.00 | (97%) 1.61M to 45.0K | (< 1%) |
| 04-Feb-14 10:58 AM View: | Critical Therapeutics Inc. (CRTX) | 03-Feb-14 | Disposition | 45,000 | $9.50 | $427,500.00 | (100%) 45.0K to 0 | (< 1%) |
| 07-Mar-13 4:12 PM View: | Critical Therapeutics Inc. (CRTX) | 05-Mar-13 | Grant | 45,000 | -- | -- | 3% 1.57M to 1.61M | |
| 03-Apr-12 4:14 PM View: | Critical Therapeutics Inc. (CRTX) | 03-Apr-12 | Market Sale | 1,443,910 | $6.25 | $9,024,460.00 | (48%) 3.01M to 1.57M | 2% |
| 20-Dec-10 6:32 PM View: | Critical Therapeutics Inc. (CRTX) | 16-Dec-10 | Market Sale | 385,000 | $6.02 | $2,317,700.00 | (11%) 3.4M to 3.01M | 2% |
| 30-Jul-09 11:53 AM View: | Critical Therapeutics Inc. (CRTX) | 28-Jul-09 | Sale Duplicate | 1,250,000 | $5.50 | $6,875,000.00 | (27%) 4.65M to 3.4M | |
| 04-Nov-08 7:50 PM View: | Critical Therapeutics Inc. (CRTX) | 31-Oct-08 | Grant | 4,646,140 | -- | -- | 145% 3.2M to 7.85M |